Fig. 2From: Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer—an east and west multicenter studyComparisons of OS between high-benefit patients,low-benefit patients and non-Adjuvant Chemotherapy patients in SEER database. Log rank (High-benefit patients vs. low-benefit patients) =0.001. Log rank(High-benefit vs. non-Adjuvant Chemotherapy) = 0.000 and Log rank(low-benefit patients vs. non-Adjuvant Chemotherapy patients) = 0.154Back to article page